Related Experiment Video
Updated: Jun 9, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Hyperhomocysteinemia and cardiovascular risks in hemodialysis patients
Mohammad Mahdi Sagheb1, Mohammad Ali Ostovan, Zahra Sohrabi
1Shiraz University of Medical Sciences, Shiraz, Iran.
Insights
In hemodialysis patients, elevated homocysteine levels correlate with cardiac issues like aortic regurgitation and left ventricular abnormalities. This study did not find reverse epidemiology, emphasizing homocysteine as a cardiac risk factor.
Area of Science:
- Nephrology
- Cardiology
- Clinical Biochemistry
Background:
- Chronic uremic patients face high risks of vascular disease, contributing to over 40% of mortality in dialysis patients.
- End-stage renal failure (ESRF) patients show significantly elevated plasma homocysteine levels, a known risk factor for cardiovascular death.
Purpose of the Study:
- To investigate the association between total plasma homocysteine levels and echocardiographic abnormalities in hemodialysis patients.
- To assess homocysteine as a predictor of cardiac disease outcomes in this population.
Main Methods:
- A cross-sectional study involving 123 adult maintenance hemodialysis patients who underwent echocardiography.
- Plasma homocysteine levels were measured and correlated with various echocardiographic parameters and patient demographics.
Main Results:
- Plasma homocysteine levels showed a direct correlation with the presence of aortic regurgitation (r=0.27, P=0.009).
- Negative correlations were observed between homocysteine and ejection fraction (r=-0.71, P=0.0001), left ventricular systolic dimension (r=-0.71, P=0.0001), and left ventricular diastolic dimension (r=-0.23, P=0.01).
- Homocysteine levels were also directly correlated with left ventricular mass index.
Conclusions:
- The study did not observe reverse epidemiology in the studied hemodialysis patients.
- Plasma total homocysteine levels are directly associated with cardiac risk factors, including left ventricular mass index and aortic regurgitation, in hemodialysis patients.
Abstract:
The risk of premature and progressive occlusive vascular disease is high in chronic uremic patients, and it accounts for more than 40% of the mortality in dialysis patients. End stage renal failure (ESRF) patients exhibit elevated plasma homocystein levels, about four fold as much as those in the controls, and it is now considered as a causative factor for increased risk of cardiovascular death among these patients. The aim of this study was to evaluate the relationship of total plasma homocysteine level and echocardiographic abnormalities as a surrogate of cardiac disease outcome in hemodialysis patients. 123 adult patients on maintenance hemodialysis and having echocardiography done during January till November 2006 were enrolled in this cross-sectional study. Plasma homocysteine level was directly related to the presence of aortic regurgitation r= 0.27 P= 0.009. There were negative correlations between ejection fraction (EF), left ventricular systolic dimension (LV.S) (r= - 0.71, P= 0.0001), left ventricular diastolic dimension (LV.D) (r= -0.23 p= 0.01) and age (r= - 0.021 P= 0.02). In conclusion we did not find the paradoxical reverse epidemiology in our patients and plasma total homocysteine level was in direct correlation with cardiac risk factors such as left ventricular mass index and aortic regurgitation.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease II: Clinical Manifestations
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemodialysis III: Nursing Management
Hemodialysis I: Introduction
Nephrotic Syndrome I : Introduction
